Phase 1b/2a trial of IT 139
Phase of Trial: Phase I/II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs IT 139 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 15 Mar 2018 According to an Intezyne media release, the company expects to initiate one or more combination Phase 1/2 studies by early 2019.
- 07 Apr 2017 New trial record
- 31 Mar 2017 According to an Intezyne media release, company plans to initiate this trial in early 2018.